Self-reported condition associated with fatigue symptoms (e.g., myalgic encephalomyelitis/chronic fatigue syndrome, long COVID, multiple sclerosis, rheumatic diseases, cancer, or fibromyalgia). G93.3 U09.9 G35 M06 M79.7
Conditions
Interventions
Group 1: At the beginning of the study (T0), standardized questionnaires are administered to assess baseline levels—particularly regarding psychological factors (e.g., self-efficacy, health locus of c
Sponsors
Universitätsklinikum Bonn (UKB)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - legal age - fluent in german - Self-reported condition associated with fatigue symptoms (e.g., myalgic encephalomyelitis/chronic fatigue syndrome, long COVID, multiple sclerosis, rheumatic diseases, cancer, or fibromyalgia).
Exclusion criteria
Exclusion criteria: - underage - not fluent in German
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-related self-efficacy; Acceptance of Illness; Health-Related Control Beliefs. The variables are assessed using established and validated measurement instruments. The SES6G (Freund et al., 2013) is used to measure health-related self-efficacy, the Questionnaire on Health-Related Control Beliefs (KKG; Lohaus & Schmitt, 1989) is used to assess locus of control regarding illness and health, and a German translation of the Acceptance of Illness Scale (Felton et al., 1984) is used to measure illness acceptance. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue severity; Quality of Life; Health Literacy; Resilience. Fatigue and Quality of Life are assessed using the PROMIS® Fatigue Short Form 8a (PROMIS Health Organization, 2018) and the PROMIS® Global Health Scale (PROMIS Health Organization, 2017), respectively. General health literacy is measured using the HLS-EU-Q16 (Röthlin et al., 2013), and resilience is assessed using the RS-13 (Leppert et al., 2008). | — |
Countries
Germany
Contacts
Public ContactSimone Dohle
Universitätsklinikum Bonn (UKB)
Outcome results
None listed